GC Green Cross participates in CEPI pandemic preparedness exercise

GC Green Cross participated in a pandemic preparedness tabletop exercise organized by CEPI, testing their mRNA vaccine development capabilities within a 100-day timeframe.

株式会社グローバルコミュニケーションズ

Cepi (Coalition For Epidemic Preparedness Innovations)

GC Green Cross ships first anthrax vaccine 'Varitrax'

GC Green Cross has shipped its first anthrax vaccine 'Varitrax', co-developed with the Korea Disease Control and Prevention Agency, 8 months after approval.

株式会社グローバルコミュニケーションズ

GC Green Cross Q1 operating profit turns positive

GC Green Cross reported Q1 operating profit of 8 billion won, turning positive from a loss last year. Sales increased 7.6% to 383.8 billion won, driven by improved blood product profitability and global sales growth of high-margin products like Alliglo.

株式会社グローバルコミュニケーションズ